|
YRDC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.86879999994638E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.27539999999982E-05 |
| Normal-vs-Stage2 |
1.083590E-02 |
| Normal-vs-Stage3 |
3.85889999999778E-05 |
| Normal-vs-Stage4 |
1.434110E-04 |
| Stage1-vs-Stage2 |
8.114200E-01 |
| Stage1-vs-Stage3 |
1.737830E-01 |
| Stage1-vs-Stage4 |
2.333600E-01 |
| Stage2-vs-Stage3 |
2.918400E-01 |
| Stage2-vs-Stage4 |
2.835600E-01 |
| Stage3-vs-Stage4 |
9.132400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.13169999999652E-05 |
| Normal-vs-AfricanAmerican |
6.038200E-02 |
| Normal-vs-Asian |
2.297900E-03 |
| Caucasian-vs-AfricanAmerican |
4.578800E-01 |
| Caucasian-vs-Asian |
9.557000E-01 |
| AfricanAmerican-vs-Asian |
4.950800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.01089999996418E-07 |
| Normal-vs-Female |
1.164120E-04 |
| Male-vs-Female |
2.253600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.916540E-03 |
| Normal-vs-Age(41-60Yrs) |
5.36109999949019E-07 |
| Normal-vs-Age(61-80Yrs) |
1.001280E-04 |
| Normal-vs-Age(81-100Yrs) |
3.189400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.605690E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.254000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.586800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.809200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.697600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.218600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.631400E-01 |
| Classical-VS-Follicular |
3.104200E-01 |
| Classical-VS-Other |
5.681800E-01 |
| Classical-VS-Normal |
9.72059999999608E-05 |
| Tall-VS-Follicular |
9.594600E-01 |
| Tall-VS-Other |
8.599000E-01 |
| Tall-VS-Normal |
3.719000E-03 |
| Follicular-VS-Other |
8.461600E-01 |
| Follicular-VS-Normal |
3.430000E-04 |
| Other-VS-Normal |
7.394200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51039999995994E-06 |
| Normal-vs-N1 |
1.021450E-03 |
| N0-vs-N1 |
8.047600E-01 |
|
|
